© 2024 Morgan Prestwich Ltd

CNX Therapeutics

CNX Therapeutics is a pharmaceutical company that aims to commercialize and supply medications specific to CNS disorders.
Morgan Prestwich have been retained on a number of positions for CNX, formerly known as Sunovion Pharmaceuticals. Morgan Prestwich supported the growth of their entire European team.

Positions placed by Morgan Prestwich included:
- Head of European Quality
- Head of European Regulatory Affairs
- VP Marketing
- Director European Market Access
- European VP Medical Affairs

Great Science Deserves Great Teams

Allow us to be part of your journey.
Great science truly deserves the greatest teams to deliver on the promise to patients, caregivers, and society in important areas of clinical need. Our promise is to identify the very best talent for each part of your journey towards building a fully integrated global Biopharmaceutical business.

Get in Touch